Aclaris Therapeutics (ACRS) to Acquire Rights to RHOFADE from Allergan (AGN) for Over $65M

October 15, 2018 4:02 PM

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to address significant ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found